RTL4
gene geneOn this page
Also known as Mart4Mar4FLJ46608SIRH11
Summary
RTL4 (retrotransposon Gag like 4, HGNC:25214) is a protein-coding gene on chromosome Xq23, encoding Retrotransposon Gag-like protein 4 (Q6ZR62). Involved in cognitive function in the brain, possibly via the noradrenergic system.
Predicted to enable nucleic acid binding activity and zinc ion binding activity. Predicted to act upstream of or within cognition and norepinephrine metabolic process.
Source: NCBI Gene 340595 — RefSeq curated summary.
At a glance
- GWAS associations: 1
- Clinical variants (ClinVar): 89 total
- MANE Select transcript:
NM_001395362
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:25214 |
| Approved symbol | RTL4 |
| Name | retrotransposon Gag like 4 |
| Location | Xq23 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | Mart4, Mar4, FLJ46608, SIRH11 |
| Ensembl gene | ENSG00000187823 |
| Ensembl biotype | protein_coding |
| OMIM | 301131 |
| Entrez | 340595 |
Gene structure
Transcript identifiers
Ensembl transcripts: 4 — 4 protein_coding
ENST00000340433, ENST00000695808, ENST00000695839, ENST00000859811
RefSeq mRNA: 2 — MANE Select: NM_001395362
NM_001004308, NM_001395362
CCDS: CCDS35369
Canonical transcript exons
ENST00000695839 — 5 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001372642 | 112454500 | 112457514 |
| ENSE00003965096 | 112431114 | 112431168 |
| ENSE00003965101 | 112130983 | 112131101 |
| ENSE00003965179 | 112083016 | 112083117 |
| ENSE00003965180 | 112306361 | 112306520 |
Expression profiles
Bgee: expression breadth broad, 23 present calls, max score 85.62.
Top tissues by expression
113 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 85.62 | gold quality |
| liver | UBERON:0002107 | 52.89 | gold quality |
| right lobe of liver | UBERON:0001114 | 49.49 | gold quality |
| prefrontal cortex | UBERON:0000451 | 46.03 | gold quality |
| mucosa of stomach | UBERON:0001199 | 43.95 | gold quality |
| cortical plate | UBERON:0005343 | 43.42 | gold quality |
| superior frontal gyrus | UBERON:0002661 | 42.05 | gold quality |
| adult mammalian kidney | UBERON:0000082 | 41.84 | gold quality |
| sural nerve | UBERON:0015488 | 40.70 | gold quality |
| frontal cortex | UBERON:0001870 | 40.63 | gold quality |
| kidney | UBERON:0002113 | 40.43 | gold quality |
| primary visual cortex | UBERON:0002436 | 40.42 | gold quality |
| hypothalamus | UBERON:0001898 | 39.78 | gold quality |
| metanephros cortex | UBERON:0010533 | 38.50 | gold quality |
| bone marrow cell | CL:0002092 | 38.45 | gold quality |
| cerebral cortex | UBERON:0000956 | 37.98 | silver quality |
| cortex of kidney | UBERON:0001225 | 37.81 | gold quality |
| colonic epithelium | UBERON:0000397 | 37.20 | gold quality |
| ventricular zone | UBERON:0003053 | 36.48 | gold quality |
| granulocyte | CL:0000094 | 36.21 | gold quality |
| ganglionic eminence | UBERON:0004023 | 35.49 | gold quality |
| substantia nigra | UBERON:0002038 | 35.09 | silver quality |
| brain | UBERON:0000955 | 34.53 | silver quality |
| skeletal muscle tissue | UBERON:0001134 | 33.38 | gold quality |
| esophagogastric junction muscularis propria | UBERON:0035841 | 33.19 | gold quality |
| bone marrow | UBERON:0002371 | 32.91 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 32.15 | gold quality |
| calcaneal tendon | UBERON:0003701 | 31.58 | gold quality |
| muscle tissue | UBERON:0002385 | 31.06 | gold quality |
| putamen | UBERON:0001874 | 30.82 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 1.98 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
111 targeting RTL4, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-518D-5P | 100.00 | 67.51 | 979 |
| HSA-MIR-518E-5P | 100.00 | 67.66 | 954 |
| HSA-MIR-518F-5P | 100.00 | 67.51 | 979 |
| HSA-MIR-519A-5P | 100.00 | 67.66 | 954 |
| HSA-MIR-519B-5P | 100.00 | 67.66 | 954 |
| HSA-MIR-519C-5P | 100.00 | 67.66 | 954 |
| HSA-MIR-520C-5P | 100.00 | 67.51 | 979 |
| HSA-MIR-522-5P | 100.00 | 67.66 | 954 |
| HSA-MIR-523-5P | 100.00 | 67.66 | 954 |
| HSA-MIR-526A-5P | 100.00 | 67.51 | 979 |
| HSA-MIR-4776-3P | 100.00 | 68.73 | 1340 |
| HSA-MIR-4425 | 100.00 | 67.59 | 1049 |
| HSA-MIR-4531 | 99.99 | 69.70 | 3181 |
| HSA-MIR-223-3P | 99.99 | 70.14 | 1140 |
| HSA-MIR-302C-5P | 99.97 | 72.56 | 3642 |
| HSA-MIR-551B-5P | 99.96 | 71.28 | 3493 |
| HSA-MIR-3143 | 99.93 | 71.96 | 3104 |
| HSA-MIR-335-3P | 99.93 | 73.36 | 4958 |
| HSA-MIR-515-5P | 99.92 | 69.82 | 2343 |
| HSA-MIR-765 | 99.84 | 68.24 | 2442 |
| HSA-MIR-548AZ-5P | 99.83 | 69.94 | 3230 |
| HSA-MIR-548T-5P | 99.83 | 69.91 | 3220 |
| HSA-MIR-944 | 99.82 | 70.85 | 3042 |
| HSA-MIR-6739-5P | 99.80 | 67.87 | 2806 |
| HSA-MIR-3913-5P | 99.78 | 67.26 | 968 |
| HSA-MIR-11181-3P | 99.75 | 66.38 | 2205 |
| HSA-MIR-6733-5P | 99.74 | 67.94 | 2759 |
| HSA-MIR-1200 | 99.71 | 70.42 | 1838 |
| HSA-MIR-3202 | 99.66 | 67.70 | 2737 |
| HSA-MIR-3679-3P | 99.64 | 69.88 | 1599 |
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Rtl4 | ENSMUSG00000071679 |
| rattus_norvegicus | Rtl4 | ENSRNOG00000031638 |
Paralogs (10): RTL8C (ENSG00000134590), RTL3 (ENSG00000179300), LDOC1 (ENSG00000182195), RTL6 (ENSG00000188636), RTL8A (ENSG00000203950), RTL8B (ENSG00000212747), RTL10 (ENSG00000215012), PEG10 (ENSG00000242265), RTL5 (ENSG00000242732), RTL1 (ENSG00000254656)
Protein
Protein identifiers
Retrotransposon Gag-like protein 4 — Q6ZR62 (reviewed: Q6ZR62)
Alternative names: Mammalian retrotransposon-derived protein 4, Zinc finger CCHC domain-containing protein 16
All UniProt accessions (1): Q6ZR62
UniProt curated annotations — full annotation on UniProt →
Function. Involved in cognitive function in the brain, possibly via the noradrenergic system.
Miscellaneous. RTL4 is one of at least 11 genes called Mar or Mart related to long terminal repeat retrotransposons. They do not correspond to functional retrotransposons, but rather to neofunctionalized retrotransposons genes.
RefSeq proteins (2): NP_001004308, NP_001382291* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001878 | Znf_CCHC | Domain |
| IPR032567 | RTL1-rel | Family |
| IPR036875 | Znf_CCHC_sf | Homologous_superfamily |
UniProt features (4 total): sequence variant 2, chain 1, zinc finger region 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q6ZR62-F1 | 49.13 | 0.00 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 28 (showing top):
GOBP_PHENOL_CONTAINING_COMPOUND_METABOLIC_PROCESS, BENPORATH_ES_WITH_H3K27ME3, GOBP_COGNITION, ATGTTAA_MIR302C, chrXq23, GOBP_NOREPINEPHRINE_METABOLIC_PROCESS, MIR3143, MIR4531, MIR4516, MIR5582_5P, MIR2113, MIR4742_3P, MIR5703, MIR4434, MIR548V
GO Biological Process (2): norepinephrine metabolic process (GO:0042415), cognition (GO:0050890)
GO Molecular Function (4): nucleic acid binding (GO:0003676), zinc ion binding (GO:0008270), protein binding (GO:0005515), metal ion binding (GO:0046872)
GO Cellular Component (0):
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| binding | 2 |
| catecholamine metabolic process | 1 |
| nervous system process | 1 |
| transition metal ion binding | 1 |
| cation binding | 1 |
Protein interactions and networks
STRING
402 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| RTL4 | RTL6 | Q6ICC9 | 771 |
| RTL4 | RTL9 | Q8NET4 | 716 |
| RTL4 | RTL8C | A6ZKI3 | 675 |
| RTL4 | LDOC1 | O95751 | 653 |
| RTL4 | RTL1 | A6NKG5 | 628 |
| RTL4 | LHFPL1 | Q86WI0 | 613 |
| RTL4 | ITGB1 | P05556 | 520 |
| RTL4 | RTL5 | Q5HYW3 | 518 |
| RTL4 | AMBP | P00977 | 507 |
| RTL4 | RTL8B | Q17RB0 | 474 |
| RTL4 | THY1 | P04216 | 430 |
| RTL4 | PEG10 | Q86TG7 | 420 |
| RTL4 | ENG | P17813 | 418 |
| RTL4 | NT5E | P21589 | 404 |
| RTL4 | LRRK1 | Q38SD2 | 394 |
IntAct
4 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| AGR2 | RTL4 | psi-mi:“MI:0915”(physical association) | 0.560 |
| AGR2 | RTL4 | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (3): ZCCHC16 (Proximity Label-MS), ZCCHC16 (Two-hybrid), ZCCHC16 (Affinity Capture-MS)
ESM2 similar proteins: A6NKG5, B0BAX9, G2TRT2, O12157, P03161, P03364, P0C2I8, P0C2J2, P0C2J4, P0C2J6, P0C691, P0CX59, P0CX60, P0CX61, P0CX62, P17192, P19558, P22281, P25383, P30028, P61511, P61512, P85051, Q03483, Q03964, Q04215, Q09T00, Q0R5R4, Q12217, Q12260, Q12266, Q12293, Q12391, Q12392, Q12439, Q12470, Q1PD56, Q3URY0, Q4R7E8, Q52QI2
Diamond homologs: Q3URY0, Q6ZR62, Q8N8U3
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
89 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 43 |
| Likely benign | 4 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
52 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| X:112455674:A:T | donor_gain | 0.9500 |
| X:112455658:G:GG | donor_gain | 0.8700 |
| X:112455657:A:AG | donor_gain | 0.8600 |
| X:112455673:G:GT | donor_gain | 0.8000 |
| X:112456171:GA:G | acceptor_gain | 0.7600 |
| X:112455662:G:GT | donor_gain | 0.6000 |
| X:112456170:A:AG | acceptor_gain | 0.5500 |
| X:112456171:G:GG | acceptor_gain | 0.5500 |
| X:112454573:GCT:G | donor_gain | 0.4100 |
| X:112457040:T:A | acceptor_gain | 0.3700 |
| X:112455465:G:T | acceptor_gain | 0.3600 |
| X:112455464:A:T | acceptor_gain | 0.3400 |
| X:112456171:G:C | acceptor_gain | 0.3400 |
| X:112455663:A:T | donor_gain | 0.3300 |
| X:112455463:TAG:T | acceptor_gain | 0.3100 |
| X:112456164:C:CT | acceptor_gain | 0.3100 |
| X:112456143:CCTA:C | acceptor_gain | 0.3000 |
| X:112456145:T:TA | acceptor_gain | 0.3000 |
| X:112456146:A:AA | acceptor_gain | 0.3000 |
| X:112454605:C:G | donor_gain | 0.2900 |
| X:112456158:TA:T | acceptor_gain | 0.2900 |
| X:112454683:ACT:A | donor_gain | 0.2800 |
| X:112455395:C:T | donor_gain | 0.2800 |
| X:112455446:C:CT | acceptor_gain | 0.2800 |
| X:112456156:TATA:T | acceptor_gain | 0.2700 |
| X:112456159:A:AG | acceptor_loss | 0.2700 |
| X:112456160:T:G | acceptor_loss | 0.2700 |
| X:112456166:TCCTA:T | acceptor_loss | 0.2700 |
| X:112456167:CCTAG:C | acceptor_loss | 0.2700 |
| X:112456168:CTAGA:C | acceptor_loss | 0.2700 |
AlphaMissense
0 scored. Top likely-pathogenic:
dbSNP variants (sampled 300 via entrez): RS1000016562 (X:112383595 T>C), RS1000018535 (X:112228121 C>T), RS1000021966 (X:112107190 A>C,G), RS1000037581 (X:112162514 G>A,C), RS1000061133 (X:112333700 G>A), RS1000063283 (X:112221419 C>T), RS1000069831 (X:112084706 T>A), RS1000077380 (X:112312522 G>C), RS1000085000 (X:112386894 A>T), RS1000133677 (X:112303887 T>C), RS1000137390 (X:112171555 A>C), RS1000138181 (X:112099369 A>G), RS1000139267 (X:112396289 C>G), RS1000153608 (X:112176890 T>A), RS1000154433 (X:112456568 T>C)
Disease associations
OMIM: gene MIM:301131 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
1 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST000328_12 | Biochemical measures | 7.000000e-06 |
EFO canonical traits (1, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004530 | triglyceride measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
6 total (human), top 6 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| bisphenol A | increases methylation, affects cotreatment | 1 |
| CGP 52608 | affects binding, increases reaction | 1 |
| Fulvestrant | affects cotreatment, increases methylation | 1 |
| Benzo(a)pyrene | decreases methylation | 1 |
| Valproic Acid | decreases methylation | 1 |
| Aflatoxin B1 | decreases methylation | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.